Huda Y. Zoghbi, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,000 shares at $850.00 ($850K) on 2023-10-13, disclosed to the SEC on 2023-10-17.
Scheduled sale ($850k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2024-01-04 | $1.0M | — | Filing → |
| REGN | SELL | 2022-03-18 | $1.4M | — | Filing → |
| REGN | SELL | 2021-09-15 | $650K | — | Filing → |